Western Sydney Kidney Injury Biopsy Study

Launched by WESTERN SYDNEY LOCAL HEALTH DISTRICT · Feb 3, 2024

Keywords

ClinConnect Summary

The Western Sydney Kidney Injury Biopsy Study is a clinical trial focused on improving how we diagnose and predict outcomes for patients with kidney injury. The researchers aim to create a new scoring system that helps doctors better understand the damage to the kidneys by analyzing tissue samples from kidney biopsies. They will use advanced techniques to look closely at the tissue and its molecular features, which can provide important information about a patient's condition.

To join this study, participants need to be between the ages of 65 and 74 or 29 and 219 and must have had a kidney biopsy at Westmead Hospital since 2000. This includes biopsies from either native kidneys or transplanted kidneys. Unfortunately, those who have never had a kidney biopsy, those whose biopsy samples are not available at Westmead, or those without information on their kidney function cannot participate. If you are eligible and choose to participate, you can expect to contribute to important research that may lead to better care for patients with kidney injury in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Had a kidney biopsy (native kidney or transplant kidney included) after year 2000
• • 2. Kidney biopsy sample sent to Westmead Hospital for clinical interpretation
• Exclusion Criteria:
• • 1. Patients who have never had a kidney biopsy performed
• • 2. Biopsy sample not available at Westmead Hospital
• • 3. No information on kidney function (serum creatinine or eGFR)